Breaking AI & Tech News Analyzed

Senegal's recent enactment of a harsh anti-gay law has sent shockwaves through the country's LGBTQ+ community and healthcare system. The law, which doubles the maximum prison term to 10 years for same-sex activities and criminalizes the 'promotion' of homosexuality, has led to a surge in arrests and a climate of fear.Over 60 people have been detained since February on charges related to same-sex relations, with many facing forced HIV testing and additional penalties for those who test positive. This has resulted in a significant decline in HIV healthcare services, with a 34.5% drop in consultations recorded at 22 treatment sites across the country.The law's broad framing also risks criminalizing legitimate human rights activities, including those of lawyers, health workers, journalists, and NGOs. This has led to organizations like UJEC (Union des Jeunes Engagés pour Notre Communauté) suspending their services, leaving vulnerable populations without access to essential support and healthcare.Senegal's HIV prevention system, which had been considered one of Africa's most resilient, is now under threat. The country's HIV prevalence among MSM is alarmingly high at 27.6%, and the new law is expected to exacerbate this issue by driving key populations underground and making them more reluctant to seek treatment or testing.The international community has expressed concern, with UNAIDS urging the president not to sign the legislation and highlighting that new HIV infections in Senegal rose by 36% between 2010 and 2024. The situation is further complicated by funding cuts and the US freeze on foreign assistance, which have already weakened the HIV response in the country.As the situation continues to unfold, there are reports of people fleeing Senegal for neighboring countries or seeking asylum in France. The Senegalese Ministry of Justice and supreme court have declined to comment, leaving many to wonder whether the country's HIV prevention system can survive this new legislation and the fear it has instilled.

Judith Rapoport, a leading child psychiatrist, passed away at 92, leaving a legacy defined by her groundbreaking work on obsessive‑compulsive disorder (OCD). Her 1989 book, The Boy Who Couldn’t Stop Washing, translated into more than twenty languages, presented complex research in a clear, jargon‑free style that resonated with a broad audience. OCD is characterized by compulsive rituals—re‑tying shoelaces, repeatedly checking switches, or incessant hand‑washing—that can dominate a person’s daily life. Before Rapoport’s book, many sufferers concealed their symptoms out of shame, unaware that they were not alone. Rapoport’s research demonstrated that OCD has a neurological foundation and may affect up to 2% of the population, challenging prevailing beliefs that it stemmed from overly strict parenting. She proved that the disorder can be hereditary and responsive to medication. In a pivotal 1989 double‑blind trial, she showed that the antidepressant clomipramine significantly reduced OCD symptoms, prompting the U.S. Food and Drug Administration to approve its use for the condition—a landmark moment in psychiatric treatment. Patients and colleagues credit her work with reducing stigma. "Reading Rapoport’s book washed away my shame," recalled Charles Gentz, who lives with OCD, while Professor Gabrielle Shapiro of the Icahn School of Medicine noted that the book “reduced the stigma for these people.” Rapoport herself reflected, “If my work alleviated just part of their pain, then it was not wasted time.” Born in New York City to a schoolteacher mother and a businessman father, she grew up with a literary lineage—her grandfather translated Ibsen into Yiddish. She excelled academically, graduating magna cum laude from Swarthmore College in 1955** and earning her medical degree from Harvard Medical School in 1959, where she met her husband, Stanley Rapoport. After early positions at Mount Sinai and the Massachusetts Mental Health Center, she and her husband secured fellowships in Sweden, conducting research at Uppsala University and the Karolinska Institute on women seeking abortions abroad. Returning to the United States, Rapoport joined the National Institute of Mental Health (NIMH) in 1976. There she led the institute’s child psychiatry branch from 1984, steering American psychiatry away from Freudian models toward a **biology‑focused** approach. Beyond OCD, she made significant contributions to the understanding of attention‑deficit hyperactivity disorder (ADHD) and childhood schizophrenia. Her 1978 study revealed that amphetamine improved concentration in both hyperactive and control children, contradicting the notion that stimulants only calm hyperactivity. Using MRI, she showed that childhood schizophrenia is progressive, involving loss of brain matter—a finding that shifted the focus from parenting to neurobiology. Rapoport’s expertise reached mainstream audiences through appearances on shows hosted by Oprah Winfrey and Larry King, further amplifying her message. By the time she retired in 2017, she had authored over 300 scientific papers, several books, and earned prestigious honors, including fellowship in the Institute of Medicine (1991) and the American Academy of Arts and Sciences (2000). Colleague Gabrielle Shapiro described her as “a pioneer who turned child psychiatry into a modern, evidence‑based discipline.” Outside the laboratory, she enjoyed music, theatre, hiking, and gardening. She is survived by her husband, two sons, and four grandsons.

Tens of thousands of people have been hired by Scale AI – a firm 49% owned by Meta – to train artificial‑intelligence models by scraping Instagram accounts, harvesting copyrighted artwork and transcribing pornographic soundtracks, according to the Guardian.Scale AI promotes its Outlier platform as a flexible, expert‑driven marketplace, recruiting professionals from medicine, physics and economics to "become the expert that AI learns from."Workers, however, say the reality diverges sharply from high‑level model refinement. They describe tasks that involve massive personal‑data scraping and content that many find morally uncomfortable.Outlier is managed by Scale AI, which holds contracts with the U.S. Pentagon and other defense companies. Its chief executive, Alexandr Wang, is hailed by Forbes as the world’s youngest self‑made billionaire, while former managing director Michael Kratsios served as science adviser to former President Donald Trump.One contractor noted that users of Meta platforms would be shocked to learn their photos and friends’ images are being harvested for AI training, with workers manually reviewing profiles to extract data.The Guardian interviewed ten Outlier contributors – many also journalists, graduate students, teachers or librarians – who took the gig work out of economic desperation. One said, "A lot of us were really desperate" and felt compelled to accept the unstable, low‑pay assignments.These gig workers, dubbed “taskers,” often feel they are training their own replacements, expressing “internalised shame and guilt” over contributing to the automation of creative professions.Law firm Clarkson, representing AI gig workers, estimates that hundreds of thousands of people worldwide now labor on platforms like Outlier. Taskers report bait‑and‑switch recruitment tactics, where advertised high salaries are replaced by lower‑paid projects after onboarding.All contributors are monitored through a tool called Hubstaff, which can screenshot browsers to verify work. While Scale AI claims the software is only for accurate payment, workers describe it as constant surveillance.Assignments have ranged from transcribing pornographic audio and labeling photos of dead animals or dog faeces, to annotating diagrams of infant genitalia and violent police scenarios. One doctoral student recounted being promised “no nudity” only to receive explicit porn clips.Scale AI says it shuts down any task flagged as inappropriate and does not accept projects involving child sexual‑abuse material or pornography, though workers note that publicly available images of minors have been used for training.Social‑media scraping tasks required workers to tag individuals by name, location and age, sometimes pulling data from accounts of users under 18. One task asked contributors to order Facebook photos by the subject’s age, prompting ethical unease.In addition to personal data, taskers were asked to harvest copyrighted artwork, with strict instructions to avoid AI‑generated images and select only hand‑drawn pieces. Scale AI maintains it does not ask workers to violate copyright standards.Scale AI’s client list includes major tech firms such as Google, Meta and OpenAI, as well as the U.S. Department of Defense and the government of Qatar, highlighting the growing demand for labelled data as AI models scale.Some workers reported interacting with ChatGPT and Claude, and speculated they might be training Meta’s upcoming model, code‑named “Avocado.”OpenAI announced it ended its partnership with Scale AI in June 2025, citing its supplier code of conduct that mandates ethical treatment of all workers.Despite irregular pay, occasional mass layoffs and the unsettling nature of many tasks, many taskers remain on the Outlier platform, hoping the AI future will eventually improve conditions. One said, "I have to be positive about AI because the alternative is not great."In response, a Scale AI spokesperson stated, "Outlier provides flexible, project‑based work with transparent pay. Contributors choose when and how they participate, and we regularly hear from highly skilled contributors who value the flexibility and opportunity to apply their expertise on the platform."

Majdi Aslan, a 54‑year‑old WHO driver, was killed on Monday when Israeli troops opened fire on a vehicle carrying World Health Organization staff in eastern Khan Younis. Several other passengers, including a WHO doctor, sustained injuries.The incident occurred near the so‑called yellow line on Salah al‑Din Street, an area that has seen near‑daily Israeli strikes since a fragile ceasefire was brokered in October. Gaza’s Health Ministry reports that more than 700 Palestinians have been killed in the renewed wave of violence.According to Al Jazeera correspondent Hani Mahmoud, Israeli forces fired indiscriminately at people and vehicles traveling along the road. A civilian commercial vehicle was followed by a car transporting WHO personnel; the WHO driver was hit in the head and later pronounced dead at Al‑Aqsa Hospital, while roughly seven others were wounded.WHO did not immediately confirm the victim’s employment but issued a statement saying a “critical security incident” had occurred and that medical evacuations from Gaza via the Rafah crossing were suspended with immediate effect. The organization has been coordinating limited patient transfers through Rafah since the crossing reopened earlier this year.The suspension comes as Israel continues to restrict humanitarian aid entry and has repeatedly closed the Rafah crossing, especially as the broader U.S.–Israel conflict with Iran draws international focus. The halt threatens the already strained access to life‑saving treatment for thousands of injured Palestinians.Elsewhere on Monday, a Palestinian man with special needs was killed by Israeli soldiers in southern Khan Younis, a drone strike in Gaza City claimed a 36‑year‑old civilian, and two more Palestinians died in drone attacks on the Yarmouk and Shujayea neighborhoods. Hospital sources say eight Palestinians have been killed by Israeli air strikes outside areas under Israeli control since Sunday.

Bangladesh’s Ministry of Health and Family Welfare disclosed that a suspected measles outbreak has killed at least 98 children in the past three weeks, prompting an urgent escalation of vaccination efforts in Dhaka’s hardest‑hit districts.Prime Minister Tarique Rahman ordered two senior ministers to tour the nation’s 170 million residents, assess the crisis’s scale, and coordinate a rapid response.Official data released on Sunday show that 6,476 children aged six months to five years exhibited measles‑like symptoms, while 826 cases have been laboratory‑confirmed with 16 confirmed deaths. Health officials note that many cases go untested, meaning the true toll could be higher.According to Halimur Rashid, director of Communicable Disease Control, “Compared with past years, the number of affected children is higher, and the death toll is higher too.” He attributes the surge to multifactorial causes, including a shortage of vaccines.World Health Organization (WHO) records indicate the highest number of suspected measles cases in Bangladesh was 25,934 in 2005. After a long decline, this year’s figures represent a stark reversal.Measles remains one of the world’s most contagious diseases, spreading through coughs and sneezes. While it can affect any age group, children under five are most vulnerable to severe complications such as brain swelling and respiratory failure. WHO estimates up to 95,000 measles deaths globally each year, primarily among unvaccinated or under‑vaccinated children.Bangladesh has previously achieved notable progress in immunisation, yet a scheduled measles‑vaccination drive for June 2024 was postponed after a violent uprising that ousted Prime Minister Sheikh Hasina. Consequently, many children—some as young as six months—missed the routine nine‑month vaccine dose.Mahmudur Rahman, chief of the National Verification Committee of Measles and Rubella, acknowledged the missed target of eliminating measles deaths by December 2025, citing “poor vaccination programmes.”In response, Dhaka has identified 30 districts with the highest case numbers and launched an emergency vaccination campaign. Health Minister Sardar Shakhawat Hossain Bakul pledged that the drive will first cover the “worst affected areas” before expanding nationwide.Public‑health expert Tajul Islam A Bari, a former official of the Expanded Programme on Immunisation, warned that although funds were allocated for vaccine procurement, the government failed to secure the doses, leading to the current “scary” situation.With no specific treatment for measles once contracted, the focus remains on accelerating vaccine delivery, improving surveillance, and preventing further loss of young lives.

Disturbing footage has emerged showing an Israeli military dog attacking a Palestinian man inside a mosque. The incident has sparked widespread concern and outrage over human rights violations and the conduct of Israeli military forces.The video, obtained from Al Jazeera, provides a harrowing glimpse into the incident, which has not been officially commented on by Israeli authorities. The lack of transparency and accountability in such cases often exacerbates tensions between Israel and Palestine.Human rights organizations have repeatedly criticized the Israeli military for its treatment of Palestinian civilians, citing numerous instances of excessive force and abuse. This latest incident is likely to fuel ongoing debates about military conduct and the need for greater oversight.

Peptides are short chains of amino acids that naturally occur in the body, acting as hormones such as insulin, oxytocin and vasopressin, or as fragments released during protein digestion.In recent years, a wave of interest has turned these molecules into purported therapeutic agents for everything from weight loss to anti‑ageing and tissue repair. Prescription drugs like semaglutide (Wegovy) and tirzepatide (Mounjaro) are synthetic peptides that have undergone rigorous clinical testing and are approved for specific medical uses.However, a large portion of the market consists of unregulated, experimental peptides sold for self‑administration. These products often bypass the strict approval processes required for medicines, raising serious safety concerns.Who is using these products? Initially confined to a niche of powerlifters and bodybuilders in the 2010s, the audience has expanded dramatically. Influential figures such as podcaster Joe Rogan have promoted combinations like the “Wolverine stack” (BPC‑157 and TB‑500) for injury recovery, while other compounds—CJC‑1295, MK‑677, ipamorelin, and GHK‑Cu—are marketed for muscle growth and anti‑ageing. Social media platforms are now flooded with instructions on purchasing and injecting these substances.Scientific backing is scant. Reviews of the literature reveal that most experimental peptides have only been tested in animal or cell models. For example, BPC‑157 shows promise for tendon and muscle repair in pre‑clinical studies, but no randomized human trials have validated these effects. Similarly, TB‑4 and its synthetic analogue TB‑500 have demonstrated limited blood‑vessel formation in laboratory settings, yet human data are absent and both are listed as prohibited substances by the World Anti‑Doping Agency.Researchers also highlight a critical knowledge gap: dosage, frequency and treatment duration remain undefined, making self‑administration a gamble.Legal landscape in the UK is clear that peptides not classified as medicines fall outside the Medicines and Healthcare products Regulatory Agency’s (MHRA) remit. If a seller makes medicinal claims, the product must hold a marketing authorisation under the Human Medicines Regulations 2012. The MHRA warns that labeling items as “research use only” does not shield vendors from enforcement when evidence shows the products are intended for human consumption.Health risks are multi‑fold. Experts caution that benefits observed in animal studies do not guarantee safety in humans. Contamination with harmful impurities or bacterial endotoxins can trigger severe reactions, including septic shock. Injecting excess natural peptides may disrupt the body’s tightly regulated hormonal balance, potentially affecting multiple physiological pathways.There is also theoretical concern that augmenting peptide levels could accelerate tumour growth, as some cancers over‑express certain peptide pathways. While no direct cases have been documented, the possibility underscores the need for caution.Additional dangers include improper injection techniques (e.g., air embolism), unknown interactions with existing medications, and the lack of systematic monitoring of long‑term effects. As one researcher put it, “If something goes wrong, users may never notice until irreversible damage has occurred.”

The UK medicines regulator has opened an inquiry into a growing number of clinics that sell injectable peptides while promoting them as cures for everything from ageing to injury recovery. The investigation, disclosed by the Guardian, focuses on whether these businesses are breaching the Human Medicines Regulations 2012 by making unauthorised medicinal claims. Interest in peptide‑based treatments has surged in recent years, driven by social‑media influencers, some healthcare professionals, and direct‑to‑consumer marketers. Yet the scientific foundation for most of these claims is weak, with the bulk of research confined to animal models or cell‑culture studies. According to an MHRA spokesperson, any clinic that advertises a peptide as having therapeutic benefits must treat the product as a medicine, which triggers a comprehensive regulatory framework. "If clinics offering peptide injections make medicinal claims for those treatments, the products will be considered medicines and subject to regulation," the agency warned, adding that it will act against any identified breaches. Guardian reporters identified several high‑ranking Google search results that list peptides such as Cortexin (promoted for neuroprotection), BPC‑157 (claimed to aid tissue repair), and Thymosin Alpha (advertised to boost immunity). After being contacted, one clinic removed the statements from its website. Another clinic, while acknowledging the limited human evidence, continued to market seven specific peptides, providing price lists (£350 per month for a single peptide, £450 for two) and offering delivery via vials, syringes, or pre‑filled pens for an additional fee. During a free consultation, a clinician highlighted the experimental nature of the products, noting the absence of large‑scale, randomised clinical trials and recommending a break of four to eight weeks between treatment cycles to mitigate unknown risks. The clinician suggested BPC‑157 for post‑exercise recovery, describing it as a facilitator of cellular repair and blood flow, but warned against its use in smokers or individuals with a family history of cancer due to potential angiogenic effects. The second peptide discussed was MOTS‑C, portrayed as a mitochondrial enhancer that could improve stress resilience, lower insulin resistance, and reduce visceral fat by boosting cellular energy production (ATP). The MHRA confirmed it is reviewing whether the clinician’s statements constitute medicinal claims. The clinic defended its approach, emphasizing that it clearly informs clients that the peptides are not licensed medicines and that the evidence base is largely pre‑clinical. In a broader statement, Lynda Scammell, head of borderline products at the MHRA, explained that peptide products may be marketed as cosmetics, supplements, or medicines, and each case is assessed on its intended use, pharmacological effect, and supporting evidence. She added, "We disregard claims that products are for ‘research purposes’ if it is clear that such claims are being used as an attempt to avoid medicines regulations." Peptides are short chains of amino acids, some of which occur naturally (e.g., insulin). While synthetic peptide analogues like semaglutide and tirzepatide have secured approval for weight‑loss treatments, many of the compounds promoted by these clinics remain experimental and lack the rigorous safety and efficacy testing required for medicinal products.

More than 100 United States‑based international law scholars have signed an open letter denouncing the recent US‑Israeli strikes on Iran as a violation of the United Nations Charter and potentially amounting to war crimes. The letter, released on Thursday, asserts that the campaign – launched on February 28 – proceeded without UN Security Council authorization and without credible evidence of an imminent Iranian threat. According to the scholars, the legal basis for force against another state exists only in self‑defence against an actual or imminent armed attack, or when expressly sanctioned by the Security Council. Iran has not attacked the United States or Israel, and the Security Council did not approve the operation. The experts organize their concerns into four categories: the legality of the war decision, the conduct of hostilities, threatening rhetoric from senior officials, and what they describe as the dismantling of civilian‑protection safeguards within the US defence establishment under Secretary of Defense Pete Hegseth’s “gloves‑off” approach. Among the most alarming incidents highlighted is the strike on a primary school in Minab, Iran on the first day of the conflict, which killed at least 175 people, the majority of them children. The letter also cites attacks on hospitals, water treatment facilities, and energy infrastructure, emphasizing that schools, health facilities, and homes have been targeted. The signatories condemn public statements by senior US officials, including a mid‑March remark by former President Donald Trump that the United States might strike Iran “just for fun,” and early‑March comments from Pentagon chief Pete Hegseth dismissing “stupid rules of engagement.” They argue that such rhetoric reflects an “alarming disrespect” for international humanitarian law, which is designed to protect civilians and combatants alike. Financially, the letter notes that the war is costing US taxpayers up to $2 billion per day, underscoring the broader economic burden of the conflict. The open letter was co‑authored by prominent legal scholars such as Yale Law School’s Oona Hathaway, former State Department legal adviser Harold Koh, NYU’s Philip Alston, and former Human Rights Watch chief Kenneth Roth. While the authors focus on the United States’ conduct, they warn of a heightened risk of atrocities throughout the region. Emphasizing the need for consistent application of international law, the scholars write: “We urge US government officials to uphold the UN Charter, international humanitarian law, and human rights law at all times, and to publicly make clear US commitment to and respect for norms of international law.”